Doenjang
Korean fermented soybean paste — long-aged, isoflavone-rich, with clinical evidence for visceral fat, blood pressure, and gut microbiome support
Doenjang is the Korean cousin of miso — a thick, savory paste made by fermenting soybeans with salt, often for a year or longer. Long aging concentrates isoflavones, peptides, and probiotic bacteria, and the resulting condiment is the backbone of soups, stews, and dipping sauces across Korea. Modern research suggests daily doenjang intake is associated with lower visceral fat, blood pressure, and metabolic syndrome risk [1][6], with mechanisms running through the gut microbiome [3] and the renin-angiotensin system [4].
What Doenjang Is and How Fermentation Changes It
Traditional doenjang starts with cooked soybeans pressed into bricks called meju, which are hung to dry and inoculated with airborne molds (Aspergillus oryzae, Bacillus subtilis) and yeasts. The bricks are then submerged in salt brine for several months. The liquid that runs off becomes Korean soy sauce; the solids, mashed and aged for another six to twenty-four months, become doenjang. Commercial doenjang is faster — single-strain koji fermentation, much shorter aging — and produces a milder, less complex paste with a different bioactive profile than long-aged traditional doenjang [7].
Three things happen during long fermentation that make doenjang nutritionally distinct from cooked soybeans:
- Isoflavone activation. Glycoside-bound isoflavones (genistin, daidzin) are cleaved by microbial β-glucosidases into the more bioavailable aglycone forms (genistein, daidzein), which is what most plasma isoflavone studies measure.
- Peptide generation. Bacillus proteases break soy protein into short peptides, some of which are angiotensin-converting enzyme (ACE) inhibitors that lower blood pressure. The dipeptide arginine-proline is one such fragment identified in fermented doenjang.
- Microbial succession. A complex consortium of Bacillus, Tetragenococcus, Lactobacillus, Pediococcus, and aspergilli colonize the paste. Some survive ingestion; others leave behind metabolites that shape the gut microbiota of the eater.
Aging time matters. Doenjang aged 24 months has roughly two to three times the antitumor activity of paste aged only 3–6 months in animal models, with parallel increases in natural killer cell activity and liver glutathione S-transferase [5].
Visceral Fat and Body Weight
The clearest human signal is in body composition. In a 12-week double-blind RCT, 51 overweight adults received either 9.9 g/day of dried doenjang (about 2 tablespoons fresh-paste equivalent) or placebo. The doenjang group showed significant reductions in body weight and visceral fat area, with no change in total or subcutaneous fat — meaning the loss came specifically from the metabolically active fat depot around the organs [1]. A follow-up trial stratifying by PPAR-γ2 C1431T genotype found that the visceral-fat benefit was concentrated in carriers of the T allele, while antioxidant effects (catalase activity, radical clearance) appeared mostly in C-allele carriers, hinting at gene-diet interaction [2].
Blood Pressure and Metabolic Syndrome
In a large cross-sectional Korean cohort of 58,701 adults, daily intake of jang (a category that includes doenjang and related fermented soybean pastes) was inversely associated with metabolic syndrome and its components — particularly waist circumference, body fat, and hypertension — even after adjusting for sodium intake. The protective association was stronger in men [6]. Mechanism studies in salt-fed rats suggest doenjang counteracts salt-induced hypertension partly by suppressing renin and increasing urinary sodium excretion, rather than simply offsetting salt with isoflavones [4].
Gut Microbiome
In a mouse study, doenjang feeding reduced the Firmicutes-to-Bacteroidetes ratio, increased Akkermansia and Lactobacillus, suppressed Enterobacteriaceae and β-glucuronidase activity, and lowered circulating lipopolysaccharide — a metabolic-endotoxemia marker tied to insulin resistance and low-grade inflammation [3]. These shifts overlap with what's seen in Akkermansia muciniphila and butyrate-producer literature.
Practical Tips
- A typical Korean serving is 1–2 tablespoons per day, used in soups (doenjang jjigae), dipping sauces (ssamjang), or stews. Most clinical effects in trials come from this amount.
- Sodium awareness. Doenjang is salty (roughly 11–14% salt by weight in traditional paste). Replacing other salty seasonings with doenjang seems to be net beneficial in cohort data, but adding it on top of an already-high-sodium diet is not the same intervention.
- Look for traditional, long-aged doenjang in Korean grocery stores — labels may say jaeraesik (traditional) versus gaeryangsik (improved/commercial). Traditional pastes have outperformed commercial pastes head-to-head on lipid and menopausal markers [7].
- Pregnant women, people on warfarin, and anyone with diagnosed soy allergy should consult a clinician before adding daily fermented soy.
- Heat handling: doenjang's Bacillus subtilis spores survive cooking, but most lactic acid bacteria don't. If probiotic bacteria matter to you, stir doenjang into already-finished soup off the heat. Isoflavones, peptides, and ACE-inhibitor activity are heat-stable.
See our fermented foods overview for context on what fermentation does to food, and miso for the closest Japanese analog.
Evidence Review
Body Composition (Human RCTs)
Cha et al. (2012) randomized 51 overweight adults to 9.9 g/day dried doenjang or placebo for 12 weeks in a double-blind design. The doenjang group showed significant reductions in body weight (−1.0 kg, p<0.05) and visceral fat area on CT (p<0.05), with no significant change in total or subcutaneous fat areas, serum lipid profile, or self-reported dietary intake. Sample size is modest and the trial was industry-supported, but the visceral-fat selectivity is mechanistically interesting and has held up in follow-up work [1].
Cha et al. (2014) extended this in a 12-week RCT stratified by PPAR-γ2 C1431T genotype (60 enrolled, 51 completers). Visceral fat reduction was significant only in T-allele carriers, while antioxidant biomarkers (catalase, total radical clearance) responded mainly in C-allele carriers. Plasma free fatty acid, insulin, and HOMA-IR rose modestly in the doenjang arm, complicating the metabolic story. The genotype-stratified design is unusual and the subgroups are small, but the effect modification is biologically plausible given PPAR-γ's role in adipocyte biology [2].
Han et al. (2024) randomized 56 perimenopausal women across three doenjang variants (traditional high-dose, traditional low-dose, commercial). All three reduced the Kupperman menopausal symptom index, with the largest decrease in the traditional low-dose group. Traditional doenjang lowered LDL cholesterol; commercial did not. Microbiome analysis showed Bacteroidetes increases in traditional high-dose and commercial groups. The trial is small and short, but the head-to-head comparison of traditional versus commercial preparations is one of the few in the literature, and it consistently favors traditional fermentation [7].
Blood Pressure and Metabolic Syndrome
Jeong et al. (2023) analyzed 58,701 adults (20,293 men; 38,408 women) from a Korean hospital-based cohort, classifying jang intake from food frequency data and adjusting for sodium and total energy. Daily jang intake was inversely associated with metabolic syndrome (especially waist circumference, body fat, and hypertension) in men, and with hypo-HDL cholesterolemia in women. Effects persisted after sodium adjustment, suggesting the association is not driven by salt substitution alone. As cross-sectional data, this cannot establish causation, but the size and direction are consistent with the smaller intervention work [6].
Mun et al. (2019) fed Sprague-Dawley rats a high-salt diet (HS) or HS plus doenjang (HSD) for 5 weeks (n=6 per group). HSD significantly reduced systolic blood pressure versus HS alone, with increased urinary and fecal sodium and potassium excretion and reduced plasma renin. The renin finding parallels what nattokinase trials show in humans, suggesting renin-angiotensin-aldosterone system (RAAS) modulation is a shared mechanism across fermented soybean foods [4].
Anticancer and Antimetastatic (Animal/In Vitro)
Jung et al. (2006) compared doenjang aged 3, 6, and 24 months in sarcoma-180 transplanted mice and a colon-26 lung metastasis model. Twenty-four-month doenjang produced two- to three-fold greater tumor inhibition than shorter-aged paste, increased splenic NK cell activity, and raised hepatic glutathione S-transferase. The mechanistic interpretation is that long aging concentrates aglycone isoflavones, melanoidins, and peptide breakdown products that drive Phase II detox enzyme induction [5]. This is animal evidence; doenjang's anticancer signal in humans is limited to ecological and case-control associations.
Gut Microbiome (Mouse Model)
Jang et al. (2014) administered doenjang to mice and observed reduced Firmicutes-to-Bacteroidetes ratio, increased Bifidobacterium, Akkermansia, Lactobacillus, and Odoribacter, decreased Enterobacteriaceae, suppressed bacterial β-glucuronidase, lowered circulating lipopolysaccharide, and increased IL-10 and PPAR-γ expression. The shifts are coherent with metabolic-syndrome-protective microbiome signatures from independent studies. Mouse-to-human translation is uncertain, but the direction overlaps with what the cohort and RCT data suggest at the phenotype level [3].
Limitations and Open Questions
- Sodium load is real. Even traditional doenjang is around 11–14% salt by weight. The cohort signal that jang reduces hypertension risk is robust, but it depends on doenjang replacing — not supplementing — other sodium sources.
- Trial sizes are small. Most human RCTs have fewer than 60 completers and run 12 weeks or less. Long-term endpoint data on cardiovascular events, cancer, or all-cause mortality with doenjang specifically are not available; what we have is biomarker-level evidence and population correlations.
- Traditional vs. commercial matters. The two head-to-head comparisons (Han 2024; aging-time studies) both favor longer-fermented traditional preparations. Off-the-shelf supermarket doenjang in Korea is mostly gaeryangsik — short-aged single-strain product — and may not deliver equivalent effects.
- Genotype interaction. The PPAR-γ2 stratification result is one of very few examples of nutrigenomic effect modification for a fermented food. It needs replication before clinical use.
Overall evidence quality: Moderate for body composition (two small RCTs, consistent direction). Moderate-to-strong for the metabolic-syndrome association (very large cohort, sodium-adjusted, biologically plausible mechanism). Mechanistic for blood pressure and microbiome (animal models converging on RAAS and microbiome pathways). Preliminary for anticancer effects.
References
- Visceral fat and body weight are reduced in overweight adults by the supplementation of Doenjang, a fermented soybean pasteCha YS, Yang JA, Back HI, Kim SR, Kim MG, Jung SJ, Song WO, Chae SW. Nutrition Research and Practice, 2012. PubMed 23346302 →
- Doenjang, a Korean fermented soy food, exerts antiobesity and antioxidative activities in overweight subjects with the PPAR-γ2 C1431T polymorphism: 12-week, double-blind randomized clinical trialCha YS, Park Y, Lee M, Chae SW, Park K, Kim Y, Lee HS. Journal of Medicinal Food, 2014. PubMed 24456362 →
- Doenjang, a fermented Korean soybean paste, inhibits lipopolysaccharide production of gut microbiota in miceJang SE, Kim KA, Han MJ, Kim DH. Journal of Medicinal Food, 2014. PubMed 24456356 →
- Effects of Doenjang, a Traditional Korean Soybean Paste, with High-Salt Diet on Blood Pressure in Sprague-Dawley RatsMun EG, Park JE, Cha YS. Nutrients, 2019. PubMed 31726743 →
- Longer aging time increases the anticancer and antimetastatic properties of doenjangJung KO, Park SY, Park KY. Nutrition, 2006. PubMed 16504476 →
- Inverse association of daily fermented soybean paste (Jang) intake with metabolic syndrome risk, especially body fat and hypertension, in men of a large hospital-based cohortJeong SJ, Yang HJ, Yang HG, Ryu MS, Ha G, Jeong DY, Park S. Frontiers in Nutrition, 2023. PubMed 36992908 →
- Evaluation of Menopausal Syndrome Relief and Anti-Obesity Efficacy of the Korean Fermented Food Doenjang: A Randomized, Double-Blind Clinical TrialHan AL, Ryu MS, Yang HJ, Jeong DY, Choi KH. Nutrients, 2024. PubMed 38674884 →
Transparency
View edit historyEvery change to this page is tracked in version control. If you have conflicting research or think something is wrong, we want to hear about it.